Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, et al. CBTRUS statistical report: main mind and different central nervous system tumors identified in the USA in 2010–2014. Neuro Oncol. 2017;19:v1–v88.
Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE. Incidence proportions of mind metastases in sufferers identified (1973 to 2001) within the metropolitan detroit most cancers surveillance system. J Clin Oncol. 2004;22:2865–72.
Sampson JH, Gunn MD, Fecci PE, Ashley DM. Mind immunology and immunotherapy in mind tumours. Nat Rev Most cancers. 2020;20:12–25.
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a abstract. Neuro Oncol. 2021;23:1231–51.
Buerki RA, Chheda ZS, Okada H. Immunotherapy of main mind tumors: details and hopes. Clin Most cancers Res. 2018;24:5198–205.
Chongsathidkiet P, Jackson C, Koyama S, Loebel F, Cui X, Farber SH, et al. Sequestration of T cells in bone marrow within the setting of glioblastoma and different intracranial tumors. Nat Med. 2018;24:1459–68.
DeCordova S, Shastri A, Tsolaki AG, Yasmin H, Klein L, Singh SK, et al. Molecular heterogeneity and immunosuppressive microenvironment in glioblastoma. Entrance Immunol. 2020;11:1402.
Liebner S, Dijkhuizen RM, Reiss Y, Plate KH, Agalliu D, Constantin G. Purposeful morphology of the blood-brain barrier in well being and illness. Acta Neuropathol. 2018;135:311–36.
Ryken TC, McDermott M, Robinson PD, Ammirati M, Andrews DW, Asher AL, et al. The position of steroids within the administration of mind metastases: a scientific overview and evidence-based scientific apply guideline. J Neurooncol. 2010;96:103–14.
Pitter KL, Tamagno I, Alikhanyan Okay, Hosni-Ahmed A, Pattwell SS, Donnola S, et al. Corticosteroids compromise survival in glioblastoma. Mind. 2016;139:1458–71.
Yang H, Xia L, Chen J, Zhang S, Martin V, Li Q, et al. Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity. Nat Med. 2019;25:1428–41.
Acharya N, Madi A, Zhang H, Klapholz M, Escobar G, Dulberg S, et al. Endogenous glucocorticoid signaling regulates CD8(+) T cell differentiation and growth of dysfunction within the tumor microenvironment. Immunity. 2020;53:658–71.e656
Collins N, Han SJ, Enamorado M, Hyperlink VM, Huang B, Moseman EA, et al. The bone marrow protects and optimizes immunological reminiscence throughout dietary restriction. Cell. 2019;178:1088–101.e1015
Cain DW, Cidlowski JA. Immune regulation by glucocorticoids. Nat Rev Immunol. 2017;17:233–47.
Sidler D, Renzulli P, Schnoz C, Berger B, Schneider-Jakob S, Flück C, et al. Colon most cancers cells produce immunoregulatory glucocorticoids. Oncogene. 2011;30:2411–9.
Islam SA, Ling MF, Leung J, Shreffler WG, Luster AD. Identification of human CCR8 as a CCL18 receptor. J Exp Med. 2013;210:1889–98.
Farmaki E, Kaza V, Papavassiliou AG, Chatzistamou I, Kiaris H. Induction of the MCP chemokine cluster cascade within the periphery by most cancers cell-derived Ccl3. Most cancers Lett. 2017;389:49–58.
Hou PP, Luo LJ, Chen HZ, Chen QT, Bian XL, Wu SF, et al. Ectosomal PKM2 promotes HCC by inducing macrophage differentiation and reworking the tumor microenvironment. Mol Cell. 2020;78:1192–206.e1110
Knipfer L, Schulz-Kuhnt A, Kindermann M, Greif V, Symowski C, Voehringer D, et al. A CCL1/CCR8-dependent feed-forward mechanism drives ILC2 capabilities in sort 2-mediated irritation. J Exp Med. 2019;216:2763–77.
Chen XJ, Wei WF, Wang ZC, Wang N, Guo CH, Zhou CF, et al. A novel lymphatic sample promotes metastasis of cervical most cancers in a hypoxic tumour-associated macrophage-dependent method. Angiogenesis. 2021;24:549–65.
Lim JY, Ryu DB, Kim TW, Lee SE, Park G, Yoon HK, et al. CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host illness (Scl-GVHD) mannequin. Stem Cell Res Ther. 2020;11:254.
King LB, Vacchio MS, Dixon Okay, Hunziker R, Margulies DH, Ashwell JD. A focused glucocorticoid receptor antisense transgene will increase thymocyte apoptosis and alters thymocyte growth. Immunity. 1995;3:647–56.
Lu FW, Yasutomo Okay, Goodman GB, McHeyzer-Williams LJ, McHeyzer-Williams MG, Germain RN, et al. Thymocyte resistance to glucocorticoids results in antigen-specific unresponsiveness on account of “holes” within the T cell repertoire. Immunity. 2000;12:183–92.
Rocamora-Reverte L, Reichardt HM, Villunger A, Wiegers G. T-cell autonomous demise induced by regeneration of inert glucocorticoid metabolites. Cell Demise Dis. 2017;8:e2948.
Li L, Zhang T, Diao W, Jin F, Shi L, Meng J, et al. Function of myeloid-derived suppressor cells in glucocorticoid-mediated amelioration of FSGS. J Am Soc Nephrol. 2015;26:2183–97.
Schweingruber N, Fischer HJ, Fischer L, van den Brandt J, Karabinskaya A, Labi V, et al. Chemokine-mediated redirection of T cells constitutes a crucial mechanism of glucocorticoid remedy in autoimmune CNS responses. Acta Neuropathol. 2014;127:713–29.
Mittelstadt PR, Monteiro JP, Ashwell JD. Thymocyte responsiveness to endogenous glucocorticoids is required for immunological health. J Clin Make investments. 2012;122:2384–94.
Shimba A, Cui G, Tani-Ichi S, Ogawa M, Abe S, Okazaki F, et al. Glucocorticoids drive diurnal oscillations in T cell distribution and responses by inducing interleukin-7 receptor and CXCR4. Immunity. 2018;48:286–98.e286
Volden PA, Conzen SD. The affect of glucocorticoid signaling on tumor development. Mind Behav Immun. 2013;30 Suppl:S26–31.
Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast most cancers survival. J Natl Most cancers Inst. 2000;92:994–1000.
Kertser A, Baruch Okay, Deczkowska A, Weiner A, Croese T, Kenigsbuch M, et al. Corticosteroid signaling on the brain-immune interface impedes dealing with extreme psychological stress. Sci Adv. 2019;5:eaav4111.
Winkler F, Venkatesh HS, Amit M, Batchelor T, Demir IE, Deneen B, et al. Most cancers neuroscience: state of the sphere, rising instructions. Cell. 2023;186:1689–707.
Seano G, Nia HT, Emblem KE, Datta M, Ren J, Krishnan S, et al. Strong stress in mind tumours causes neuronal loss and neurological dysfunction and might be reversed by lithium. Nat Biomed Eng. 2019;3:230–45.
Momin A, Bahrampour S, Min HK, Chen X, Wang X, Solar Y, et al. Channeling pressure within the mind: mechanosensitive ion channels choreograph mechanics and malignancies. Tendencies Pharm Sci. 2021;42:367–84.
Ayasoufi Okay, Pfaller CK, Evgin L, Khadka RH, Tritz ZP, Goddery EN, et al. Mind most cancers induces systemic immunosuppression via launch of non-steroid soluble mediators. Mind. 2020;143:3629–52.
Xiong SY, Wen HZ, Dai LM, Lou YX, Wang ZQ, Yi YL, et al. A brain-tumor neural circuit controls breast most cancers development in mice. J Clin Make investments. 2023;133:e167725b.
Music L, Cao L, Liu R, Ma H, Li Y, Shang Q, et al. The crucial position of T cells in glucocorticoid-induced osteoporosis. Cell Demise Dis. 2020;12:45.
Guo B, Huang X, Cooper S, Broxmeyer HE. Glucocorticoid hormone-induced chromatin reworking enhances human hematopoietic stem cell homing and engraftment. Nat Med. 2017;23:424–8.
Zhang L, Prak L, Rayon-Estrada V, Thiru P, Flygare J, Lim B, et al. ZFP36L2 is required for self-renewal of early burst-forming unit erythroid progenitors. Nature. 2013;499:92–96.
Flygare J, Rayon Estrada V, Shin C, Gupta S, Lodish HF. HIF1alpha synergizes with glucocorticoids to advertise BFU-E progenitor self-renewal. Blood. 2011;117:3435–44.
Ozga AJ, Chow MT, Luster AD. Chemokines and the immune response to most cancers. Immunity. 2021;54:859–74.
Eruslanov E, Stoffs T, Kim WJ, Daurkin I, Gilbert SM, Su LM, et al. Growth of CCR8(+) inflammatory myeloid cells in most cancers sufferers with urothelial and renal carcinomas. Clin Most cancers Res. 2013;19:1670–80.
Das S, Sarrou E, Podgrabinska S, Cassella M, Mungamuri SK, Feirt N, et al. Tumor cell entry into the lymph node is managed by CCL1 chemokine expressed by lymph node lymphatic sinuses. J Exp Med. 2013;210:1509–28.
Ruckes T, Saul D, Van Snick J, Hermine O, Grassmann R. Autocrine antiapoptotic stimulation of cultured grownup T-cell leukemia cells by overexpression of the chemokine I-309. Blood. 2001;98:1150–9.
Gajewski TF, Corrales L, Williams J, Horton B, Sivan A, Spranger S. Most cancers immunotherapy targets based mostly on understanding the T cell-inflamed versus non-T cell-inflamed tumor microenvironment. Adv Exp Med Biol. 2017;1036:19–31.
Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune cells within the tumor microenvironment. Nat Immunol. 2013;14:1014–22.
Keskin DB, Anandappa AJ, Solar J, Tirosh I, Mathewson ND, Li S, et al. Neoantigen vaccine generates intratumoral T cell responses in section Ib glioblastoma trial. Nature. 2019;565:234–9.
Wang T, Zhang H, Qiu W, Han Y, Liu H, Li Z. Biomimetic nanoparticles instantly rework immunosuppressive microenvironment for reinforcing glioblastoma immunotherapy. Bioact Mater. 2022;16:418–32.
Berenguer J, Lagerweij T, Zhao XW, Dusoswa S, van der Stoop P, Westerman B, et al. Glycosylated extracellular vesicles launched by glioblastoma cells are adorned by CCL18 permitting for mobile uptake by way of chemokine receptor CCR8. J Extracell Vesicles. 2018;7:1446660.
Choi S, Zhang B, Ma S, Gonzalez-Celeiro M, Stein D, Jin X, et al. Corticosterone inhibits GAS6 to manipulate hair follicle stem-cell quiescence. Nature. 2021;592:428–32.
